Overview
Neurologist Elizabeth Fracica specializes in the diagnosis, treatment and prevention of cerebrovascular disease and the diagnosis and treatment of neurovestibular and ocular motor disorders. Her clinical practice focuses on care for patients with cerebrovascular disorders as well as treatment of patients with disorders of the brainstem, cerebellum, and cranial nerves, including double vision, nystagmus and vertigo. Dr. Fracica has been involved in several initiatives focusing on institutional clinical process and guideline development to help improve care for patients with dizziness and stroke. She was also involved in the creation of a novel quality measure to rate patient harm due to emergency department misdiagnosis of dizzy patients with stroke, called the Avoid H.A.R.M.—ED Stroke/Dizziness measure. Her research has been published in high-ranking medical journals, including the Journal of the American Medical Association and Frontiers in Stroke, and she has presented her work at national conferences. She is a member of the American Heart Association and the American Academy of Neurology. Dr. Fracica earned her medical degree from the Mayo Clinic Alix School of Medicine in Rochester, Minnesota. She completed an internship in internal medicine at Johns Hopkins Bayview Medical Center, followed by residency training in neurology at The Johns Hopkins Hospital. Her fellowship training includes a vestibular and oculo-motor oto-neurology fellowship at Johns Hopkins and a vascular neurology fellowship at Massachusetts General Hospital. Dr. Fracica holds a master’s degree in public health from the Johns Hopkins Bloomberg School of Public Health. She joined the Johns Hopkins Department of Neurology faculty in 2024.
Her clinical expertise encompasses Stroke and Vertigo.
Dr. Fracica is board certified in American Board Of Psychiatry And Neurology. She is actively involved in clinical research, co-authoring 10 peer reviewed articles. Dr. Fracica is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4940 Eastern Avenue, Suite 1201, Baltimore, MD 21224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is highly rated in 27 conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy. Dr. Blakeley is board certified in American Board Of Psychiatry And Neurology. Dr. Blakeley is currently accepting new patients.
Johns Hopkins University
Peter Calabresi is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Calabresi is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and CACH Syndrome. Dr. Calabresi is currently accepting new patients.
Johns Hopkins Hospital
John Laterra is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Laterra is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Laterra is currently accepting new patients.
Frequently Asked Questions about Dr. Elizabeth A. Fracica
How do I make an appointment with Dr. Elizabeth A. Fracica?
You can book an appointment with Dr. Elizabeth A. Fracica by calling their office at 410-550-5624. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Elizabeth A. Fracica a top-rated expert for Stroke?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elizabeth A. Fracica is classified as an Experienced expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Elizabeth A. Fracica specialize in?
While Dr. Elizabeth A. Fracica is a Neurology, they have specific expertise in Stroke, Vertigo. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.
Does Dr. Elizabeth A. Fracica participate in research or clinical trials?
Yes. Dr. Elizabeth A. Fracica has published 10 articles and abstracts on conditions like Stroke. You can view a list of Dr. Elizabeth A. Fracica's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Elizabeth A. Fracica accept my insurance?
Dr. Elizabeth A. Fracica accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 410-550-5624 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- StrokeDr. Fracica isExperienced. Learn about Stroke.
- VertigoDr. Fracica isExperienced. Learn about Vertigo.